- Home
- KURA vs ABX Comparison
KURA vs ABX Comparison
Compare KURA & ABX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KURA | ABX |
|---|---|---|
| Founded | 2014 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 830.1M | 725.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | KURA | ABX |
|---|---|---|
| Price | $8.35 | $8.40 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $26.88 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 481.7K |
| Earning Date | 02-26-2026 | 03-26-2026 |
| Dividend Yield | N/A | ★ 2.38% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.12 |
| Revenue | $104,029,000.00 | ★ $196,551,131.00 |
| Revenue This Year | $88.72 | $97.86 |
| Revenue Next Year | $68.75 | $18.09 |
| P/E Ratio | ★ N/A | $70.83 |
| Revenue Growth | N/A | ★ 91.93 |
| 52 Week Low | $5.41 | $4.60 |
| 52 Week High | $12.49 | $9.61 |
Technical Indicators
Market Signals| Indicator | KURA | ABX |
|---|---|---|
| Relative Strength Index (RSI) | 44.59 | 53.37 |
| Support Level | $7.50 | $7.18 |
| Resistance Level | $8.08 | $8.34 |
| Average True Range (ATR) | 0.34 | 0.50 |
| MACD | 0.07 | 0.05 |
| Stochastic Oscillator | 68.99 | 83.40 |
Price Performance
Historical ComparisonAbout KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
About ABX Abacus Global Management Inc. Class A Common Stock
Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The Company organizes its business into five reportable segments Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. Its operations are confined to the United States.